444luminespib auy922 chr2797s55746 servier 1 vipadenant v2006 v158411inflammationrpl554researchpartneringoverview why partner out licensingluminespib auy922 v158866v158411in licensingresearch collaborationsconferencescurrent partnersinvestor centrefinancial reports and accountspresentations and webcastscorporate governanceanticipated newsflowregulatory announcementsrule 26 informationshareholder informationkey factsshare price informationadvisors and investor contactsanalyst coverageshareholder servicesadr programmefaqsmedia centreregulatory announcementspresentations and webcastsmedia contactslatest releases2015 releases2014 releases2013 releases2012 releasescontact uscontact informationmaps and directionscontact form commercial pipeline vernalis collaboration with tris latest status of the programmes for the us prescription market . nce pipeline see at a glance what vernalis has in development see the status of all programmes vernalis research vernalis research is a world leader in structure and fragment based drug discovery . you are here home commercial nce pipeline research latest report and accounts 30 june 2016 2015 16 results download our latest report ... archive latest presentation 29 september 2016 our latest presentation is available to view from here ... archive share price share price 39.57 pchange 0.43 1.07 % as at 14 october 2016 18 15 01volume 88 040lse id ver share price details latest news results announcement for the 12 months ended 30 june 2016 vernalis plc lse ver today announces its audited results for the 12 month period ended 30 june 2016 . read more ... at a glance more information on vernalis and its pipeline ... company fact sheet explore the pipeline ... contact vernalis t 0118 938 0000 f 0118 938 0001 contact informationmaps and directionscontact form to report suspected adverse reactions contact vernalis therapeutics inc. at 1 855 705 9546 and drugsafety propharmagroup.com or fda at 1 800 fda 1088 or www.fda.gov medwatch 2016 vernalis all rights reserved company registration and address detailsterms and conditionsglossaryprivacy policy javascript is currently disabled.please enable it for a better experience of jumi .